🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial tests the safety, side effects, and best dose of nivolum...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2022-11-03
Trial ID
NCT05272384
Multicentric phase II trial to evaluate efficacy and safety of ibrutinib in...
Status
Completed
Location
Hospital Universitario Son Espases
Start Date
2016-04-07
Trial ID
NCT02692248
Treatments Being Tested
The aim of this study is to evaluate functional and physical capacity, heal...
Status
Unknown
Location
LUHS hospital Kaunas Clinics Rehabilitation hospital of Kulautuva
Start Date
2020-01-06
Trial ID
NCT04768283
Treatments Being Tested
This is a prospective, single-arm, multicenter, phase II clinical trial to ...
Status
Not Yet Recruiting
Location
Daping Hospital, Third Military Medical University (Army Medical University)
Start Date
2025-02-01
Trial ID
NCT06778902
Treatments Being Tested
This study is to define the safety profile and to determine the Maximal tol...
Status
Terminated
Location
Mayo Clinic
Start Date
2017-04-24
Trial ID
NCT02908451
Treatments Being Tested
A multicenter, prospective, open, randomized cohort, non controlled phase I...
Status
Completed
Location
Jie Ge
Start Date
2023-04-11
Trial ID
NCT06009627
The purpose of this study was to study the efficacy of PPSB-SD and VP-VI in...
Status
Completed
Location
University Hospital Gasthuisberg
Start Date
2002-03
Trial ID
NCT00151853
Treatments Being Tested
Fever is the most frequent symptom in patients seeking care globally. Sever...
Status
Completed
Location
LOMWRU, Mahosot Hospital
Start Date
2019-11-12
Trial ID
NCT04299607
Treatments Being Tested
Influenza virus is a significant pathogen in pediatric solid organ transpla...
Status
Recruiting
Location
Stanford University
Start Date
2024-09-26
Trial ID
NCT05947071
Etoposide-cisplatin/ -carboplatin in combination with PD-L1 inhibitor for 4...
Status
Completed
Location
Hunan cancer hospital
Start Date
2020-06-01
Trial ID
NCT04636762
Treatments Being Tested